0001437749-18-012234.txt : 20180621
0001437749-18-012234.hdr.sgml : 20180621
20180621163048
ACCESSION NUMBER: 0001437749-18-012234
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180619
FILED AS OF DATE: 20180621
DATE AS OF CHANGE: 20180621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Klausner Mark R.
CENTRAL INDEX KEY: 0001732629
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36200
FILM NUMBER: 18912113
MAIL ADDRESS:
STREET 1: C/O OXFORD IMMUNOTEC GLOBAL
STREET 2: 94C INNOVATION DRIVE, MILTON PARK
CITY: ABINGDON, OXFORDSHIRE
STATE: X0
ZIP: OX14 4RZ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oxford Immunotec Global PLC
CENTRAL INDEX KEY: 0001586049
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
BUSINESS PHONE: 44 01235 442780
MAIL ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
4
1
rdgdoc.xml
FORM 4
X0306
4
2018-06-19
0001586049
Oxford Immunotec Global PLC
OXFD
0001732629
Klausner Mark R.
C/O OXFORD IMMUNOTEC GLOBAL
94C INNOVATION DRIVE
ABINGDON, OXFORDSHIRE
X0
OX14 4RZ
UNITED KINGDOM
1
SHARE OPTION (RIGHT TO BUY)
14.49
2018-06-19
4
A
0
7457
0
A
2028-06-19
ORDINARY SHARES
7457
7457
D
The option will vest and become exercisable as to 100% of the underlying shares on the date of the first annual meeting of the issuer's shareholders held after the date of grant.
/s/ Anthony P. Ferman, as Attorney-in-Fact for Mark Klausner
2018-06-21